loading
Edgewise Therapeutics Inc stock is traded at $32.30, with a volume of 47,159. It is up +1.13% in the last 24 hours and down -7.29% over the past month. Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
See More
Previous Close:
$31.95
Open:
$32.37
24h Volume:
47,159
Relative Volume:
0.04
Market Cap:
$3.03B
Revenue:
-
Net Income/Loss:
$-115.88M
P/E Ratio:
-24.10
EPS:
-1.34
Net Cash Flow:
$-104.72M
1W Performance:
-1.70%
1M Performance:
-7.29%
6M Performance:
+80.60%
1Y Performance:
+409.62%
1-Day Range:
Value
$31.71
$32.80
1-Week Range:
Value
$29.82
$33.21
52-Week Range:
Value
$5.93
$38.12

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Name
Name
Edgewise Therapeutics Inc
Name
Phone
720-262-7002
Name
Address
1715 38TH ST, BOULDER
Name
Employee
108
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
EWTX's Discussions on Twitter

Compare EWTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
EWTX 32.30 3.03B 0 -115.88M -104.72M -1.34
VRTX 447.55 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.92 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.88 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.41 24.49B 3.30B -501.07M 1.03B 11.54

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-01-23 Initiated Truist Buy
Aug-25-22 Downgrade Goldman Neutral → Sell
Apr-13-22 Initiated RBC Capital Mkts Outperform
Jan-28-22 Initiated Goldman Neutral

Edgewise Therapeutics Inc Stock (EWTX) Latest News

pulisher
Nov 16, 2024

FY2024 Earnings Estimate for EWTX Issued By Leerink Partnrs - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

What is Leerink Partnrs' Forecast for EWTX FY2024 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 13, 2024

Orbimed Advisors LLC Adjusts Stake in Edgewise Therapeutics Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Reduces Stake in Edgewise Therapeutics Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Learn to Evaluate (EWTX) using the Charts - Stock Traders Daily

Nov 12, 2024
pulisher
Nov 11, 2024

Edgewise Therapeutics Reports Third Quarter Financial Results and Business Highlights - Defense World

Nov 11, 2024
pulisher
Nov 08, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $45.00 - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Edgewise Therapeutics Inc. (EWTX) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Edgewise boosts R&D spending with drug trials underway - BizWest

Nov 07, 2024
pulisher
Nov 07, 2024

Edgewise Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Edgewise Therapeutics stock hits 52-week high at $36.71 - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Edgewise Therapeutics stock hits 52-week high at $36.71 By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

Critical Analysis: Prestige Consumer Healthcare (NYSE:PBH) versus Edgewise Therapeutics (NASDAQ:EWTX) - Defense World

Nov 06, 2024
pulisher
Nov 03, 2024

abrdn plc Purchases Shares of 256,645 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Nov 03, 2024
pulisher
Oct 31, 2024

Edgewise Therapeutics shares maintain price target on positive data By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 27, 2024

Novo Holdings A S Sells 794,530 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

Moody Aldrich Partners LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 24, 2024
pulisher
Oct 17, 2024

Edgewise Therapeutics stock hits 52-week high at $35.34 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Edgewise Therapeutics stock hits 52-week high at $35.34 By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 16, 2024

Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 32.99, Up 3.68 - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

Top investors say Edgewise Therapeutics Inc (EWTX) ticks everything they need - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighShould You Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Is it possible to buy Edgewise Therapeutics Inc(EWTX) shares at a good price now? - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

EWTX (Edgewise Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

SG Americas Securities LLC Sells 34,544 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Piper Sandler Increases Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $51.00 - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Minimal stock impact anticipated for Edgewise Therapeutics stock even with potential CK miss - Investing.com Canada

Oct 11, 2024
pulisher
Oct 11, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.5% Following Analyst Upgrade - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $51.00 at Piper Sandler - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

(EWTX) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Edgewise Therapeutics Inc (EWTX) Stock: Navigating Drops and Gains - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

Chief Scientific Officer Russell Alan J sold 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month HighTime to Buy? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

A look into Edgewise Therapeutics Inc (EWTX)’s deeper side - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Financial Analysis: Edgewise Therapeutics Inc (EWTX)’s Ratios Unveil Key Insights - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

Was there any good news for Edgewise Therapeutics Inc (EWTX) stock in the last session? - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Dimensional Fund Advisors LP Buys 168,219 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now - Yahoo Finance

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down – Here’s What Happened - Defense World

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics Inc [EWTX] Insider Activity: An Update for Investors - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Squarepoint Ops LLC Purchases 27,687 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Oct 07, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Purchases 613,251 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% HigherStill a Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% Higher – Still a Buy? - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Hypertrophic Cardiomyopathy Market Expected to Experience - openPR

Oct 04, 2024
pulisher
Oct 04, 2024

Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart

Oct 04, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics Insiders Sold US$2.6m Of Shares Suggesting Hesitancy - Simply Wall St

Oct 04, 2024
pulisher
Oct 03, 2024

Chief Scientific Officer Russell Alan J sale 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily

Oct 03, 2024

Edgewise Therapeutics Inc Stock (EWTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Edgewise Therapeutics Inc Stock (EWTX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Russell Alan J
Chief Scientific Officer
Sep 20 '24
Option Exercise
0.18
75,000
13,500
87,719
Russell Alan J
Chief Scientific Officer
Sep 20 '24
Sale
28.27
75,000
2,120,101
12,719
MOORE JOHN R
General Counsel
Sep 20 '24
Option Exercise
0.71
50,000
35,500
53,252
MOORE JOHN R
General Counsel
Sep 23 '24
Option Exercise
0.71
20,922
14,855
24,174
MOORE JOHN R
General Counsel
Sep 20 '24
Sale
28.37
50,000
1,418,510
3,252
MOORE JOHN R
General Counsel
Sep 23 '24
Sale
27.63
20,922
578,064
3,252
Donovan Joanne M.
CMO
Sep 20 '24
Sale
28.29
7,162
202,603
14,538
Derakhshan Behrad
Chief Business Officer
Sep 20 '24
Option Exercise
1.93
42,068
81,191
57,189
Derakhshan Behrad
Chief Business Officer
Sep 20 '24
Sale
29.03
42,068
1,221,133
15,121
Carruthers R Michael
Chief Financial Officer
Sep 20 '24
Option Exercise
1.93
96,068
185,411
81,996
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):